{"id":"NCT02472886","sponsor":"Gilead Sciences","briefTitle":"Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection","officialTitle":"A Phase 3b, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06-17","primaryCompletion":"2016-03-30","completion":"2016-06-30","firstPosted":"2015-06-16","resultsPosted":"2017-05-10","lastUpdate":"2018-11-16"},"enrollment":153,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C Virus Infection"],"interventions":[{"type":"DRUG","name":"LDV/SOF","otherNames":["HarvoniÂ®","GS-5885/GS-7977"]},{"type":"DRUG","name":"RBV","otherNames":[]}],"arms":[{"label":"LDV/SOF","type":"EXPERIMENTAL"},{"label":"LDV/SOF Coinfected with HIV-1","type":"EXPERIMENTAL"},{"label":"LDV/SOF+RBV Retreatment","type":"EXPERIMENTAL"}],"summary":"The primary objectives of this study are to evaluate the antiviral efficacy, safety, and tolerability of ledipasvir/sofosbuvir (LDV/SOF) fixed dose combination (FDC) with or without ribavirin (RBV) in adults with chronic hepatitis C virus (HCV) infection.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response 12 Weeks After Discontinuation of Therapy (SVR12)","timeFrame":"Posttreatment Week 12","effectByArm":[{"arm":"LDV/SOF 8 Weeks (TN, HCV-monoinfected)","deltaMin":100,"sd":null},{"arm":"LDV/SOF 8 Weeks (TN, HCV/HIV-coinfected)","deltaMin":96.6,"sd":null},{"arm":"LDV/SOF + RBV 12 Weeks (TE, SOF-treated, HCV-monoinfected)","deltaMin":96.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":6},"locations":{"siteCount":20,"countries":["Estonia","Russia"]},"refs":{"pmids":["29177645"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":67},"commonTop":["Headache","Abdominal pain upper","Dyspepsia","Asthenia","Irritability"]}}